Malnutrition and Weight Loss as Prognostic Factors in the Survival of Patients with Gastric Cancer

References

• World Health Organization. Cancer [Online]2021. Available: https://www.who.int/news-room/fact-sheets/detail/cancer. [Accessed 1.4.2021 2021].
   Google Scholar
• Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F, Negri E, La Vecchia C, Lunet N. Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype. Eur J Cancer. 2014;50(7):1330–44.
   PubMed Web of Science ®Google Scholar
• GLOBOCAN. Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 [Online]2012. Available: http://www.globocaniarcfr/Pages/fact_sheets_canceraspx. [Accessed 1.4.2021 2021].
   Google Scholar
• Movahedi M, Afsharfard A, Moradi A, Nasermoaddeli A, Khoshnevis J, Fattahi F, Akbari ME. Survival rate of gastric cancer in Iran. J Res Med Sci. 2009;14(6):367–73.
   PubMed Web of Science ®Google Scholar
• Stewart BW, Kleihues P. World cancer report 2003.
   Google Scholar
• Hosseinnataj A, RezaBaneshi M, Bahrampour A. Mortality risk factors in patients with gastric cancer using Bayesian and ordinary Lasso logistic models: a study in the Southeast of Iran. Gastroenterol Hepatol Bed Bench. 2020;13(1):31–6.
   PubMedGoogle Scholar
• van Bokhorst-De Van Der Schueren MA, Quak JJ, von Blomberg-van der Flier BM, Kuik DJ, Langendoen SI, Snow GB, Green CJ, van Leeuwen PA. Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severely malnourished head and neck cancer patients. Am J Clin Nutr. 2001;73(2):323–32.
   PubMed Web of Science ®Google Scholar
• Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Cancer: disease and nutrition are key determinants of patients’ quality of life. Support Care Cancer. 2004;12(4):246–52. doi:10.1007/s00520-003-0568-z
   PubMed Web of Science ®Google Scholar
• Tian J, Chen Z-c, Hang L-f. The effects of nutrition status of patients with digestive system cancers on prognosis of the disease. Cancer Nurs. 2008;31(6):462–7. doi:10.1097/01.NCC.0000339247.60700.86
   PubMed Web of Science ®Google Scholar
• Nikniaz Z, Somi MH, Nagashi S, Nikniaz L. Impact of early enteral nutrition on nutritional and immunological outcomes of gastric cancer patients undergoing gastrostomy: a systematic review and meta-analysis. Nutr Cancer. 2017;69(5):693–701. doi:10.1080/01635581.2017.1324996
   PubMed Web of Science ®Google Scholar
• Liu X, Qiu H, Kong P, Zhou Z, Sun X. Gastric cancer, nutritional status, and outcome. OTT. 2017;ume 10:2107–14. doi:10.2147/OTT.S132432
   Web of Science ®Google Scholar
• Yang Y, Gao P, Song Y, Sun J, Chen X, Zhao J, Ma B, Wang Z. The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: a meta-analysis. Eur J Surg Oncol. 2016;42(8):1176–82. doi:10.1016/j.ejso.2016.05.029
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhu J-Y, Zhou L-N, Tang M, Chen M-B, Tao M. Predicting the prognosis of gastric cancer by albumin/globulin ratio and the prognostic nutritional index. Nutr Cancer. 2020;72(4):635–44. doi:10.1080/01635581.2019.1651347
   PubMed Web of Science ®Google Scholar
• Detsky AS, Baker J, Johnston N, Whittaker S, Mendelson R, et al. What is subjective global assessment of nutritional status? J Parenter Enter Nutr. 1987;11:8–13.
   PubMed Web of Science ®Google Scholar
• Shahabbasi J, Jager-Wittenaar H, Ottery F, Asghari-Jafarabadi M, Ghoreishy Z, et al. Cross-Cultural Adaptation and Validation of the" Patient-Generated Subjective Global Assessment (PG-SGA)" for Nutritional Status Assessment of Cancer Patients. Depic Health. 2018;9:149–58.
   Google Scholar
• Okamoto Y, Okano K, Izuishi K, Usuki H, Wakabayashi H, Suzuki Y. Attenuation of the systemic inflammatory response and infectious complications after gastrectomy with preoperative oral arginine and ω-3 fatty acids supplemented immunonutrition. World J Surg. 2009;33(9):1815–21. doi:10.1007/s00268-009-0140-1
   PubMed Web of Science ®Google Scholar
• Andreoli A, De Lorenzo A, Cadeddu F, Iacopino L, Grande M. New trends in nutritional status assessment of cancer patients. Eur Rev Med Pharmacol Sci. 2011;15(5):469–80.
   PubMed Web of Science ®Google Scholar
• Seo SH, Kim S-E, Kang Y-K, Ryoo B-Y, Ryu M-H, Jeong JH, Kang SS, Yang M, Lee JE, Sung M-K, et al. Association of nutritional status-related indices and chemotherapy-induced adverse events in gastric cancer patients. BMC Cancer. 2016;16(1):900. doi:10.1186/s12885-016-2934-5
   PubMed Web of Science ®Google Scholar
• Chaves MR, Boleo-Tome C, Monteiro-Grillo I, Camilo M, Ravasco P. The diversity of nutritional status in cancer: new insights. The Oncologist. 2010;15(5):523–30. doi:10.1634/theoncologist.2009-0283
   PubMed Web of Science ®Google Scholar
• Segura A, Pardo J, Jara C, Zugazabeitia L, Carulla J, de Las Peñas R, García-Cabrera E, Luz Azuara M, Casadó J, Gómez-Candela C, et al. An epidemiological evaluation of the prevalence of malnutrition in Spanish patients with locally advanced or metastatic cancer. Clin Nutr. 2005;24(5):801–14. doi:10.1016/j.clnu.2005.05.001
   PubMed Web of Science ®Google Scholar
• Tchekmedyian N, Zahyna D, Halpert C, Heber D. Assessment and maintenance of nutrition in older cancer patients. Oncology (Williston Park). 1992;6(2 Suppl):105–11.
   PubMedGoogle Scholar
• Chen X-L, Xue L, Wang W, Chen H-N, Zhang W-H, Liu K, Chen X-Z, Yang K, Zhang B, Chen Z-X, et al. Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study. Oncotarget. 2015;6(38):41370–82. doi:10.18632/oncotarget.5629
   PubMedGoogle Scholar
• Bourke CD, Berkley JA, Prendergast AJ. Immune dysfunction as a cause and consequence of malnutrition. Trends Immunol. 2016;37(6):386–98. doi:10.1016/j.it.2016.04.003
   PubMed Web of Science ®Google Scholar
• Shen Q, Liu W, Quan H, Pan S, Li S, Zhou T, Ouyang Y, Xiao H. Prealbumin and lymphocyte-based prognostic score, a new tool for predicting long-term survival after curative resection of stage II/III gastric cancer. Br J Nutr. 2018;120(12):1359–69. doi:10.1017/S0007114518002854
   PubMed Web of Science ®Google Scholar
• Xiao Y, Xie Z, Shao Z, Chen W, Xie H, Qin G, Zhao N. Neutrophil and lymphocyte counts at diagnosis are associated with overall survival of pancreatic cancer: A retrospective cohort study. Medicine (Baltimore). 2016;95(40):e5024. doi:10.1097/MD.0000000000005024
   PubMed Web of Science ®Google Scholar
• Miyoshi Y, Yoshimura Y, Saito K, Muramoto K, Sugawara M, et al. High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin—but not with treatment of physician’s choice—in the EMBRACE study. Breast Cancer. 2020;27(4):706–715. doi:10.1007/s12282-020-01067-2
   PubMed Web of Science ®Google Scholar
• Chen L, Hao Y, Zhu L, Li S, Zuo Y, Zhang Y, Song H, Xue Y. Monocyte to lymphocyte ratio predicts survival in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy. OTT. 2017;10:4007–16. doi:10.2147/OTT.S140118
   Web of Science ®Google Scholar